<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0">
<channel>
<title>News for Halozyme Therapeutics, Inc. - Google Finance</title>
<description>News for Halozyme Therapeutics, Inc. - Google Finance</description>
<link>http://www.google.com/finance?q=NASDAQ:HALO&amp;amp;client=news-rss&amp;amp;ei=MdScUbCoF-K50QHeTA</link>
<image>
<title>News for Halozyme Therapeutics, Inc. - Google Finance</title>
<url>/finance/s/M4XFgDr56u4/images/logo_us.gif</url>
<link>http://www.google.com/finance?q=NASDAQ:HALO&amp;amp;client=news-rss&amp;amp;ei=MdScUbCoF-K50QHeTA</link>
</image>
<item>
<title>Stocks to Watch: Tellabs, Inc. (NASDAQ:TLAB), Curis, Halozyme Therapeutics ...</title>
<link>http://www.sbwire.com/press-releases/stocks-to-watch-tellabs-inc-nasdaqtlab-curis-halozyme-therapeutics-wave-systems-corp-254802.htm</link>
<guid isPermaLink="false">tag:finance.google.com,cluster:43982068517976</guid>
<pubDate>Tue, 21 May 2013 13:00:21 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.sbwire.com/press-releases/stocks-to-watch-tellabs-inc-nasdaqtlab-curis-halozyme-therapeutics-wave-systems-corp-254802.htm&quot; style=&quot;font-size:1.2em&quot;&gt;Stocks to Watch: Tellabs, Inc. (NASDAQ:TLAB), Curis, Halozyme Therapeutics ...&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;SBWire (press release)&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;May 21, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;Tellabs, Inc. (NASDAQ:TLAB) shares declined 6.48% to $2.02. The company on May 20 said that CFO Andrew Szafran has resigned for personal reasons.&lt;/div&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>Halozyme Therapeutics Inc (NASDAQ:HALO) up by 5.51% in pre-market trade ...</title>
<link>http://gdpinsider.com/halozyme-therapeutics-inc-nasdaqhalo-up-by-5-51-in-pre-market-trade-boulder-brands-inc-nasdaqbdbd-1596.html</link>
<guid isPermaLink="false">tag:finance.google.com,cluster:http://gdpinsider.com/halozyme-therapeutics-inc-nasdaqhalo-up-by-5-51-in-pre-market-trade-boulder-brands-inc-nasdaqbdbd-1596.html</guid>
<pubDate>Fri, 17 May 2013 13:41:26 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://gdpinsider.com/halozyme-therapeutics-inc-nasdaqhalo-up-by-5-51-in-pre-market-trade-boulder-brands-inc-nasdaqbdbd-1596.html&quot; style=&quot;font-size:1.2em&quot;&gt;Halozyme Therapeutics Inc (NASDAQ:HALO) up by 5.51% in pre-market trade ...&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;GSPInsider&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;May 17, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;Halozyme Therapeutics, Inc (NASDAQ:HALO): In Friday&amp;#39;s trading session, Halozyme Therapeutics, Inc (NASDAQ:HALO) up by 5.51%.&lt;/div&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>HALOZYME THERAPEUTICS, INC. : Baxter Receives Marketing Authorization ...</title>
<link>http://www.4-traders.com/HALOZYME-THERAPEUTICS-IN-50245/news/Halozyme-Therapeutics-Inc-Baxter-Receives-Marketing-Authorization-for-HyQvia-in-European-Union-16899238/</link>
<guid isPermaLink="false">tag:finance.google.com,cluster:43982068517899</guid>
<pubDate>Tue, 21 May 2013 14:26:47 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.4-traders.com/HALOZYME-THERAPEUTICS-IN-50245/news/Halozyme-Therapeutics-Inc-Baxter-Receives-Marketing-Authorization-for-HyQvia-in-European-Union-16899238/&quot; style=&quot;font-size:1.2em&quot;&gt;HALOZYME THERAPEUTICS, INC. : Baxter Receives Marketing Authorization ...&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;4-traders (press release)&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;23 hours ago &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;BRUSSELS--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX) and Halozyme Therapeutics, Inc., (NASDAQ:HALO) today announced that the European Commission has granted Baxter marketing authorization in all European Union (EU) Member ...&lt;/div&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>Positive trend for Halozyme Therapeutics Inc. (NASDAQ:HALO), Ruckus ...</title>
<link>http://gdpinsider.com/positive-trend-for-halozyme-therapeutics-inc-nasdaqhalo-ruckus-wireless-inc-nyserkus-1572.html</link>
<guid isPermaLink="false">tag:finance.google.com,cluster:http://gdpinsider.com/positive-trend-for-halozyme-therapeutics-inc-nasdaqhalo-ruckus-wireless-inc-nyserkus-1572.html</guid>
<pubDate>Fri, 17 May 2013 06:45:03 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://gdpinsider.com/positive-trend-for-halozyme-therapeutics-inc-nasdaqhalo-ruckus-wireless-inc-nyserkus-1572.html&quot; style=&quot;font-size:1.2em&quot;&gt;Positive trend for Halozyme Therapeutics Inc. (NASDAQ:HALO), Ruckus ...&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;GSPInsider&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;May 17, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;Halozyme Therapeutics, Inc. (NASDAQ:HALO) closed up to $7.98 after gaining 18.40% during the day and hitting its day&amp;#39;s high of $8.06 and a low of $7.25.&lt;/div&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>Canadian Solar Inc. (NASDAQ:CSIQ) down by 1.49%, Halozyme Therapeutics ...</title>
<link>http://gdpinsider.com/canadian-solar-inc-nasdaqcsiq-down-by-1-49-halozyme-therapeutics-inc-nasdaqhalo-1526.html</link>
<guid isPermaLink="false">tag:finance.google.com,cluster:43982063315259</guid>
<pubDate>Thu, 16 May 2013 10:06:43 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://gdpinsider.com/canadian-solar-inc-nasdaqcsiq-down-by-1-49-halozyme-therapeutics-inc-nasdaqhalo-1526.html&quot; style=&quot;font-size:1.2em&quot;&gt;Canadian Solar Inc. (NASDAQ:CSIQ) down by 1.49%, Halozyme Therapeutics ...&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;GSPInsider&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;May 16, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;Halozyme Therapeutics Inc. (NASDAQ:HALO) closed up by $0.45 at $7.74 in the Wednesday&amp;#39;s trading session. The share price of Halozyme hit a high of $7.27 and a low of $6.73 during the day, after opening at $6.97.&lt;/div&gt;
&lt;a href=&quot;http://www.streetinsider.com/Analyst+Comments/Wedbush+Sees+No+Need+to+Own+Halozyme+(HALO)/8346747.html&quot;&gt;Wedbush Sees No Need to Own Halozyme (HALO)&lt;/a&gt; - &lt;span style=&quot;color:#888888&quot;&gt;StreetInsider.com (subscription)&lt;/span&gt;&lt;br&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>HALOZYME THERAPEUTICS, INC. : HALO, NTAP, INFI and DRYS added to ...</title>
<link>http://www.4-traders.com/HALOZYME-THERAPEUTICS-IN-50245/news/Halozyme-Therapeutics-Inc-HALO-NTAP-INFI-and-DRYS-added-to-Nasdaq-Active-Stock-Watch-List-at-E-16869843/</link>
<guid isPermaLink="false">tag:finance.google.com,cluster:http://www.4-traders.com/HALOZYME-THERAPEUTICS-IN-50245/news/Halozyme-Therapeutics-Inc-HALO-NTAP-INFI-and-DRYS-added-to-Nasdaq-Active-Stock-Watch-List-at-E-16869843/</guid>
<pubDate>Fri, 17 May 2013 13:36:38 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.4-traders.com/HALOZYME-THERAPEUTICS-IN-50245/news/Halozyme-Therapeutics-Inc-HALO-NTAP-INFI-and-DRYS-added-to-Nasdaq-Active-Stock-Watch-List-at-E-16869843/&quot; style=&quot;font-size:1.2em&quot;&gt;HALOZYME THERAPEUTICS, INC. : HALO, NTAP, INFI and DRYS added to ...&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;4-traders (press release)&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;May 17, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;... Inc. (NASDAQ:INFI) and DryShips, Inc. (NASDAQ:DRYS). Halozyme Therapeutics, Inc. (NASDAQ:HALO) a biopharmaceutical company that concentrates on the development of human enzymes finished yesterday at (+18.40%) on 5,329,593 shares traded.&lt;/div&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>Forbes Earnings Preview: Halozyme Therapeutics, Inc.</title>
<link>http://www.forbes.com/sites/narrativescience/2013/05/06/forbes-earnings-preview-halozyme-therapeutics-inc/</link>
<guid isPermaLink="false">tag:finance.google.com,cluster:http://www.forbes.com/sites/narrativescience/2013/05/06/forbes-earnings-preview-halozyme-therapeutics-inc/</guid>
<pubDate>Mon, 06 May 2013 16:13:55 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.forbes.com/sites/narrativescience/2013/05/06/forbes-earnings-preview-halozyme-therapeutics-inc/&quot; style=&quot;font-size:1.2em&quot;&gt;Forbes Earnings Preview: Halozyme Therapeutics, Inc.&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;Forbes&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;May 6, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;Analysts are expecting Halozyme Therapeutics to come in with a loss of 15 cents per share, more than year-earlier reported loss of 14 cents per share.&lt;/div&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>Stocks To Watch: SolarCity Corp, Halozyme Therapeutics Inc, E Commerce ...</title>
<link>http://theopenglobe.com/stocks-to-watch-solarcity-corp-halozyme-therapeutics-inc-e-commerce-china-dangdang-inc-aviva-plc/12984/</link>
<guid isPermaLink="false">tag:finance.google.com,cluster:http://theopenglobe.com/stocks-to-watch-solarcity-corp-halozyme-therapeutics-inc-e-commerce-china-dangdang-inc-aviva-plc/12984/</guid>
<pubDate>Thu, 16 May 2013 14:53:26 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://theopenglobe.com/stocks-to-watch-solarcity-corp-halozyme-therapeutics-inc-e-commerce-china-dangdang-inc-aviva-plc/12984/&quot; style=&quot;font-size:1.2em&quot;&gt;Stocks To Watch: SolarCity Corp, Halozyme Therapeutics Inc, E Commerce ...&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;Openglobe&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;May 16, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;Halozyme Therapeutics, Inc. (NASDAQ:HALO) shares jumped 12.31% to $7.57. The company, on May 15, announced that clinical data from a Phase 1b trial of PEGPH20 (PEGylated Recombinant Human Hyaluronidase), an investigational new biologic, ...&lt;/div&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>NASDAQ Gainers Watch List: Halozyme Therapeutics, Inc. (NASDAQ:HALO ...</title>
<link>http://www.sbwire.com/press-releases/nasdaq-gainers-watch-list-halozyme-therapeutics-inc-nasdaqhalo-and-mylan-inc-nasdaqmyl-added-to-growing-stock-reports-nasdaq-gainers-watch-list-252904.htm</link>
<guid isPermaLink="false">tag:finance.google.com,cluster:43982060517752</guid>
<pubDate>Thu, 16 May 2013 15:43:12 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.sbwire.com/press-releases/nasdaq-gainers-watch-list-halozyme-therapeutics-inc-nasdaqhalo-and-mylan-inc-nasdaqmyl-added-to-growing-stock-reports-nasdaq-gainers-watch-list-252904.htm&quot; style=&quot;font-size:1.2em&quot;&gt;NASDAQ Gainers Watch List: Halozyme Therapeutics, Inc. (NASDAQ:HALO ...&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;SBWire (press release)&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;May 16, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;Halozyme Therapeutics, Inc. (NASDAQ:HALO) a biopharmaceutical company that engages in the research, development, and commercialization of human enzymes is currently up (+18.25%) on 2,717,587 shares traded after Halozyme Announced To Present ...&lt;/div&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>NASDAQ PERCENTAGE GAINERS: Eagle Bulk Shipping Inc., Halozyme ...</title>
<link>http://www.sbwire.com/press-releases/nasdaq-percentage-gainers-eagle-bulk-shipping-inc-halozyme-therapeutics-inc-hutchinson-technology-incorporated-tesaro-inc-252848.htm</link>
<guid isPermaLink="false">tag:finance.google.com,cluster:http://www.sbwire.com/press-releases/nasdaq-percentage-gainers-eagle-bulk-shipping-inc-halozyme-therapeutics-inc-hutchinson-technology-incorporated-tesaro-inc-252848.htm</guid>
<pubDate>Thu, 16 May 2013 14:48:45 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.sbwire.com/press-releases/nasdaq-percentage-gainers-eagle-bulk-shipping-inc-halozyme-therapeutics-inc-hutchinson-technology-incorporated-tesaro-inc-252848.htm&quot; style=&quot;font-size:1.2em&quot;&gt;NASDAQ PERCENTAGE GAINERS: Eagle Bulk Shipping Inc., Halozyme ...&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;SBWire (press release)&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;May 16, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;Huntington Beach, CA -- (SBWIRE) -- 05/16/2013 -- PSPicks.com provides its subscribers with a free newsletter that reports up to the minute information and exclusive charts on cheap, undervalued, hidden, and undiscovered stocks traded on the NASDAQ, ...&lt;/div&gt;
&lt;/div&gt;
</description>
</item>
</channel>
</rss>
